CIK 0001725160
- Non-accelerated filer
- Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 823607803
- Phone
- +1 858-263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- 4 Open-market sale President & CEO sold 26,799 shares at an average $66.33 ($1,777,707)
- 4 Open-market sale Director sold 12,896 shares at an average $66.35 ($855,588)
- 4 Open-market sale Director sold 10,000 shares at an average $67.52 ($675,229)
- 4 Open-market sale President & CEO sold 26,794 shares at an average $67.50 ($1,808,716)
- 4 Open-market sale Chief Operating Officer sold 8,420 shares at an average $67.49 ($568,283)
- 4 Open-market buy Chief Financial Officer bought 9,611 shares at an average $52.00 ($499,748)
- 4 Open-market sale President & CEO sold 26,794 shares at an average $50.88 ($1,363,337)
- 4 Open-market sale Chief Operating Officer sold 8,420 shares at an average $51.05 ($429,805)
- 4 Open-market sale Director sold 10,000 shares at an average $51.02 ($510,198)
- 4 Open-market sale President & CEO sold 42,849 shares at an average $46.99 ($2,013,602)
- 4 Open-market sale Director sold 18,370 shares at an average $46.92 ($861,856)
- 4 Open-market sale Chief Operating Officer sold 24,812 shares at an average $46.94 ($1,164,675)
- 4 Open-market sale Chief Operating Officer sold 8,420 shares at an average $51.23 ($431,367)
- 4 Open-market sale Chief Financial Officer sold 3,083 shares at an average $51.27 ($158,054)
- 4 Open-market sale President & CEO sold 26,794 shares at an average $51.21 ($1,372,235)
- 4 Open-market sale Director sold 10,000 shares at an average $49.58 ($495,827)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Open-market sale Director sold 10,000 shares at an average $54.06 ($540,551)
- 4 Open-market sale Chief Operating Officer sold 8,420 shares at an average $54.09 ($455,442)
Page 9 of 13 · 252 filings